Sunday, June 13, 2021

LATEST ARTICLES

Kite’s Tecartus® Demonstrates High Response Rate in Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

SANTA MONICA, Calif.-- Kite, a Gilead Company (Nasdaq: GILD), announced today results from the primary analysis of ZUMA-3, a global, multicenter, single-arm, open-label Phase...

Janux Therapeutics Appoints Dr. Wayne Godfrey as Chief Medical Officer

SAN DIEGO-- Janux Therapeutics, a biopharmaceutical company developing novel T cell engager immunotherapies, today announced the appointment of Wayne Godfrey, M.D., as Chief Medical...

venBio Raises $550 Million Venture Capital Fund Focused on Life Sciences

SAN FRANCISCO-- venBio today announced the closing of venBio Global Strategic Fund IV, LP (“venBio Fund IV”), its fourth life sciences venture capital fund,...

Bayer Acquires Noria and PSMA Therapeutics to Expand Pipeline in Prostate Cancer

WHIPPANY, N.J.-- Bayer today announced that it has entered into an agreement to acquire Noria Therapeutics Inc. (Noria) and PSMA Therapeutics Inc. Through this...

Blackstone Has Acquired Desotec

CHICAGO-- Lincoln International, a global investment banking advisory firm, has advised Blackstone on the acquisition of Desotec. Based in Roeselare, Belgium, Desotec’s mission is to...

Harvard Licenses Technology to Obatala Sciences to Advance Discovery in Obesity, Diabetes, and Cancer

CAMBRIDGE, Mass. & NEW ORLEANS-- Harvard University has granted an exclusive license to biotechnology company Obatala Sciences to commercialize innovations that enable the study...

Cytovale Begins Enrollment in FDA 510(k) Clinical Validation Study of IntelliSep Rapid Sepsis Test

SAN FRANCISCO-- Cytovale, a medical diagnostics company focused on providing a faster, more insightful way to diagnose fast-moving and immune-mediated diseases, today announced the...

Nayya Raises $37 Million in Series B Growth Capital, co-led by SVB Capital and ICONIQ Growth

NEW YORK-- Nayya, a leading insurance benefits experience and healthcare management platform, today announced that it has raised $37M in Series B financing, co-led...

Oxford Finance Provides $24 Million Credit Facility to Lantern Group

ALEXANDRIA, Va. -- Oxford Finance LLC (“Oxford”), a leading specialty finance firm providing senior debt to healthcare services and life sciences companies worldwide, today...

Inspira Health Appoints Warren E. Moore, FACHE as the New Executive Vice President, Chief Operating Officer

MULLICA HILL, N.J.-- Inspira Health today announced the appointment of Warren E. Moore, FACHE, to Executive Vice President, Chief Operating Officer, effective immediately. Moore...

Most Popular

Recent Comments